Lecturer in Microbiology and Medical Biotechnology

Contact Details

Office: Dav103
Email: benjamin.evans@anglia.ac.uk
Phone: +44 (0)1223 363271 (ext 2059)

Qualifications

PhD in Medical Microbiology, University of Edinburgh

Personal Profile

2012 - Present: Lecturer, Anglia Ruskin University
2011 - 2012: Post-doctoral Research Associate, Institute of Integrative Biology, University of Liverpool
2009 - 2011: Post-doctoral Research Associate, Faculty of Life Sciences, University of Manchester
2006 - 2009: PhD in Medical Microbiology, University of Edinburgh

Teaching experience

Module leader: Professional and Ethical Practice in Industry (MSc)

Other modules:
General Microbiology
Core Biology
Diagnostics in Pathology
Microbial Applications
Principles of Genetics
Preparation for Research
Microbial Pathogenicity
Techniques in DNA Analysis (MSc)

Research Interests

My research interests are in the evolution of bacterial pathogens and antimicrobial resistance. Current research projects include examining the diversity and evolution of Pseudomonas aeruginosa in chronic infections of the Cystic Fibrosis lung; understanding the evolution of natural transformation in Streptococcus pneumoniae; and establishing the epidemiology of multidrug-resistant Acinetobacter baumannii and the evolution of associated antibacterial resistance mechanisms.

Publications

A. A. Al-Sultan, B. A. Evans, E. A. Elsayed, S. I. Al-Thawadi, A. Y. Al-Taher, S. G. B. Amyes, A. M. Al-Dughaym & A. Hamouda (2013). High frequency of carbapenem-resistant Acinetobacter baumannii in patients with Diabetes Mellitus in Saudi Arabia. Journal of Medical Microbiology, 62; 885-888. DOI 10.1099/jmm.0.057216-0

B. A. Evans & Rozen DE (2013). Significant variation in transformation frequency in Streptococcus pneumoniae. The ISME Journal, 7; 791-799. DOI: 10.1038/ismej.2012.170

B. A. Evans, A. Hamouda & S. G. B. Amyes (2012). The rise of carbapenem-resistant Acinetobacter baumannii. Current Pharmaceutical Design, 19(2):223-238.

B. A. Evans & D. E. Rozen (2012). A Streptococcus pneumoniae infection model in larvae of the wax moth Galleria mellonella. European Journal of Clinical Microbiology and Infectious Diseases, 31 (10); 2653-60. DOI: 10.1007/s10096-012-1609-7.

B. Lopes, B.A. Evans and S. G. B. Amyes (2012). The disruption of the blaOXA-51-like gene by ISAba16 and the activation of the blaOXA-58 gene leading to carbapenem resistance in Acinetobacter baumannii Ab244. Journal of Antimicrobial Chemotherapy, 67; 59-63.

B. A. Evans & L. Emery (2011). What is PCR? Biological Sciences Review, Nov; 20-21.

K. J. Towner, B. A. Evans, L. Villa, K. Levi, A. Hamouda, S. G. B. Amyes & A. Carattoli (2011). Distribution of Intrinsic Plasmid Replicase Genes and their Association with Carbapenem-Hydrolyzing Class D ß-Lactamase Genes in European Clinical Isolates of Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, 55 (5); 2154 - 2159.

B. A. Evans, A. Hamouda, S. A. Abbasi, F. A. Khan & S. G. B. Amyes (2011). High prevalence of un-related multidrug-resistant Acinetobacter baumannii isolates in Pakistani military hospitals. International Journal of Antimicrobial Agents, 37 (6); 580 - 581.

N. Jiricny, S. P. Diggle, S. A. West, B. A. Evans, G. Ballantyne, A. Ross-Gillespie & A. S. Griffin (2010). Fitness correlates with the extent of cheating in a bacterium. Journal of Evolutionary Biology, 23(4); 738- 747.

J. Yang, B. A. Evans & D. E. Rozen (2010). Signal diffusion and the mitigation of social exploitation in pneumococcal competence signalling. Proceedings of the Royal Society London B - Biology, 277; 2991- 2999.

B. A. Evans, A. Hamouda, K. J. Towner & S. G. B. Amyes (2010). Novel genetic context of multiple blaOXA- 58 genes in Acinetobacter genospecies 3. Journal of Antimicrobial Chemotherapy, 65 (8); 1586-1588.

A. Hamouda, B. A. Evans, K. J. Towner & S. G. B. Amyes (2010). Characterisation of epidemiologically unrelated Acinetobacter baumannii isolates from four continents using Multilocus Sequence Typing, Pulsed-Field Gel Electrophoresis and Sequence-Based Typing of blaOXA-51-like genes. Journal of Clinical Microbiology, 48; 2476-2483.

A. Alsultan, A. Hamouda, B. A. Evans & S. G. B. Amyes (2009). Acinetobacter baumannii: emergence of four strains with novel blaOXA-51-like genes in patients with diabetes mellitus. Journal of Chemotherapy, 21(3); 290-295.

B. A. Evans, A. Hamouda, K. J. Towner & S. G. B. Amyes (2008). OXA-51-like beta-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii. Clinical Microbiology and Infection, 14; 268-275.

B. A. Evans, S. Brown, A. Hamouda, J. Findlay & S. G. B. Amyes (2007). Eleven novel OXA-51-like enzymes from clinical isolates of Acinetobacter baumannii. Clinical Microbiology and Infection, 13(11); 1137-1138.

B. A. Evans, A. Hamouda & S. G. B. Amyes (2007). OXA-type beta-lactamases in Acinetobacter baumannii: emerging from the shadow of the extended-spectrum beta-lactamases. Reviews in Medical Microbiology, 18(4); 63-72.


Media

Cambridge News, 14 May 2013. Deadly superbug poses diabetic patients greater risk, Anglia Ruskin University reveals.